✦ LIBER ✦

MP-19.08: Reduced dose BCG is effective in carcinoma in situ (CIS) of the bladder: long term results of a phase ii study

✍ Scribed by M. Brausi; G. Verrini; M. Gavioli; G.C. Peracchia; G. De Luca; G. Giliberto; M. Viola; G.L. Simonini

Book ID: 116948223
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 73 KB
Volume: 70
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2007.06.543

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

LOW DOSE BACILLUS CALMETTE-GUERIN FOR CA

LOW DOSE BACILLUS CALMETTE-GUERIN FOR CARCINOMA IN SITU OF THE BLADDER: LONG-TERM RESULTS

✍ LOSA, A.; HURLE, R.; LEMBO, A. 📂 Article 📅 2000 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 100 KB

INTENSIVE DOSE GEMCITABINE IN CIS OF THE

INTENSIVE DOSE GEMCITABINE IN CIS OF THE BLADDER: FIRST RESULTS OF A PHASE II STUDY

✍ Gontero, Paolo; Fiorito, Chiara; Lucca, Ilaria; Tizzani, Alessandro; Brausi, Mau 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 137 KB

1006 17 year follow-up of the Nordic CIS

1006 17 year follow-up of the Nordic CIS study: Long-term results of 1 year BCG monotherapy versus alternating therapy with mitomycin C and BCG in patients with carcinoma in situ of the urinary bladder

✍ Kaasinen, E.; Wijkström, H.; Malmström, P-U.; Rintala, E.; Jahnsson, S. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 109 KB

189 SEQUENTIAL CHEMO-IMMUNOTHERAPY WITH

189 SEQUENTIAL CHEMO-IMMUNOTHERAPY WITH MITOMYCIN C (MMC) AND BACILLUS CALMETTE-GUERIN (BCG) VERSUS BCG ALONE IN PATIENTS WITH CARCINOMA IN SITU (CIS) OF THE URINARY BLADDER. RESULTS OF EORTC GU GROUP RANDOMIZED PHASE II STUDY 30993

✍ W. Oosterlinck; Z. Kirkali; R.J. Sylvester; F. Calais Da Silva; C. Busch; F. Alg 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 83 KB

1474 SEQUENTIAL CHEMO-IMMUNOTHERAPY WITH

1474 SEQUENTIAL CHEMO-IMMUNOTHERAPY WITH MITOMYCIN C (MMC) AND BACILLUS CALMETTE-GUERIN (BCG) VERSUS BCG ALONE IN PATIENTS WITH CARCINOMA IN SITU (CIS) OF THE URINARY BLADDER. RESULTS OF EORTC GU GROUP RANDOMIZED PHASE II STUDY 30993

✍ Kirkali, Ziya; Oosterlinck, Willem; Sylvester, Richard; Calais Da Silva, Fernand 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 44 KB

MP-20.17: Dose Reduction of Bacillus Cal

MP-20.17: Dose Reduction of Bacillus Calmette-Guérin (BCG) in the Treatment of Carcinoma In Situ(CIS) of the Bladder with a Less Intense and Shorter Maintenance Regimen: A 15 Year Experience

✍ A. Sommerhuber; M. Mayr; W. Loidl 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 128 KB